Opportunity Information: Apply for PAR 22 213

The NIH funding opportunity PAR 22-213, titled "Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)," supports large, coordinated aging research programs built around a single, clearly defined scientific question or theme relevant to aging. The intent is to fund projects that are too large or too interdependent to be handled well as a set of separate grants, and that genuinely require multiple integrated components working together. Applications are expected to describe a complex, multi-part research effort where the pieces are scientifically linked and collectively designed to answer a central question in aging research, rather than a loose collection of independent studies.

This opportunity uses the U19 mechanism, which is a cooperative agreement. In practice, that means the NIH is not simply providing funds and stepping back; instead, the funded team should anticipate ongoing scientific or programmatic involvement from the NIH during the life of the award. The FOA is also labeled "Clinical Trial Optional," meaning applicants may include a clinical trial component if it is appropriate for the overall integrated project, but a clinical trial is not required. The emphasis is on tightly connected, multidisciplinary work that benefits from coordination, shared resources, and an overall management structure that keeps the components aligned.

Projects funded under this FOA will typically involve multidisciplinary investigator teams, either within a single institution or across a consortium of institutions. The structure is meant for research that needs multiple interacting parts, such as different projects, cores, shared methods, coordinated data approaches, or other components that depend on each other to succeed. Reviewers will generally expect the application to make a strong case that integration is essential, explaining how the different parts inform one another, how coordination will be handled, and how the overall design improves scientific payoff compared with smaller or stand-alone studies.

Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations (including both 501(c)(3) and non-501(c)(3) nonprofits) other than institutions of higher education; for-profit organizations other than small businesses; small businesses; public housing authorities/Indian housing authorities; and Native American tribal governments (federally recognized) as well as Native American tribal organizations that are not federally recognized tribal governments. The FOA also explicitly highlights additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal government agencies, regional organizations, Indian/Native American tribal governments other than federally recognized, and U.S. territories or possessions.

At the same time, the FOA places clear limits on foreign involvement. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply as the applicant organization. In addition, non-domestic components of U.S. organizations are not eligible to apply. However, foreign components are allowed as defined in the NIH Grants Policy Statement, which generally means a U.S. applicant can include certain types of foreign collaboration or subcomponents when they are well-justified and meet NIH policy requirements.

From an administrative standpoint, this is a discretionary funding opportunity under the health category, with assistance listing CFDA number 93.866, and it is administered by the National Institutes of Health. The FOA was created on 2022-07-07, and the listed original closing date is 2025-09-25. The source information provided does not specify an award ceiling or the expected number of awards, which typically means applicants should rely on the full FOA text and NIH guidance for budgeting expectations and any institute- or program-specific constraints.

Overall, the opportunity is best suited for applicants who can propose a cohesive, high-impact aging research program that demands strong integration across multiple research components, supported by a management and collaboration plan capable of handling the complexity of a cooperative agreement. The most competitive proposals will usually be the ones that make the integration feel necessary rather than optional, show how the team and infrastructure are set up to operate as one coordinated effort, and demonstrate a clear pathway to advancing aging-related science through the combined contributions of all components.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2022-07-07.
  • Applicants must submit their applications by 2025-09-25. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 22 213

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required)

Previous opportunity: Bureau of Land Management New Mexico Plant Conservation and Restoration Management

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 22 213

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 22 213) also looked into and applied for these:

Funding Opportunity
New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed) Apply for RFA HL 23 016

Funding Number: RFA HL 23 016
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) Apply for PAR 22 169

Funding Number: PAR 22 169
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
More Monitoring of Cognitive Change, Continued (M3C3) (U2C Clinical Trial Optional) Apply for RFA AG 23 021

Funding Number: RFA AG 23 021
Agency: National Institutes of Health
Category: Health
Funding Amount: $4,800,000
Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R21 Clinical Trial Not Allowed) Apply for RFA MH 22 281

Funding Number: RFA MH 22 281
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R01 Clinical Trial Not Allowed) Apply for RFA MH 22 280

Funding Number: RFA MH 22 280
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) Apply for PAR 22 193

Funding Number: PAR 22 193
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 22 192

Funding Number: PAR 22 192
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) Apply for PAR 22 189

Funding Number: PAR 22 189
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) Apply for RFA TR 22 029

Funding Number: RFA TR 22 029
Agency: National Institutes of Health
Category: Health
Funding Amount: $325,000
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed) Apply for PAR 22 190

Funding Number: PAR 22 190
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Postdoctoral Research Associate Training (PRAT) Program (Fi2) Apply for PAR 22 191

Funding Number: PAR 22 191
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed) Apply for PAR 22 212

Funding Number: PAR 22 212
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Understanding Persistent Signs and Symptoms Attributed to Post-Treatment Lyme Disease (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 046

Funding Number: RFA AI 22 046
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Early Liver Transplantation Cohort Study for Alcohol-associated Liver Diseases (Collaborative R01 Clinical Trial Not Allowed) Apply for RFA AA 22 003

Funding Number: RFA AA 22 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (R61/R33 Clinical Trial Not Allowed) Apply for RFA NS 22 055

Funding Number: RFA NS 22 055
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition for the Continuation of Clinical Sites for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed) Apply for RFA NS 23 004

Funding Number: RFA NS 23 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional) Apply for RFA MH 22 185

Funding Number: RFA MH 22 185
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Geroscience Course (R25 Independent Clinical Trial Not Allowed) Apply for PAR 22 214

Funding Number: PAR 22 214
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Postbaccalaureate Research Education Program (PREP)(R25 - Independent Clinical Trial Not Allowed) Apply for PAR 22 220

Funding Number: PAR 22 220
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (R42 Fast-Track - Clinical Trial Not Allowed) Apply for RFA DE 23 007

Funding Number: RFA DE 23 007
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 22 213", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: